Member Info for Burmesepython

I think that's his lot. He needed to ot a tax bill and the RNS has stated that clearly. Like I said he never sold when the so was over £4, instead he bought more @ £2.76 back in October.

Can't buy more than 50k shares online

Difficult to buy. Buys showing as sells @1.35

Buy Reported today from the 4th of May. That's 250000 shares @ £1.50. If you scroll down to trades around 12noon. ;-)))

He could've sold over £4 last year but instead bought in last Octobers placing @ £2.76.

Tax bill is all it was to satisfy. Onwards & upwards from here.

Bought in 6 months ago @ �2.76 which was at 15% discount. �2M in the bank. Business is as robust as ever and Haris Chaudhry owns about half the shares in the company. Only 14m shares in issue.

Will set this off big time.

£2M in the bank with revenues rolling in line with expectations !! £2.76 was the last placing price without this world class Prolong product approved by the FDA!!

Prolong is now FDA approved and same in Australia. The only Erectile dysfunction product to get the Seal from the US FDA that's a permanent non prescription cure. 1 in 2 Americans suffer from ED and 1 in 3 in Australia. Uk & Europe next for Prolong. Wait till the penny drops and this is 5-10 bagger. Add al the other products they have which are rolled out on an international scale & the Chairman owning half of the 14Million shares in issue this is re rating as we speak.

Perfect for the next leg up here on more news. Last trading update said they look forward to releasing more products. Wonder what they have in store!!

Media coverage as well. This is going global this PROLONG. This is massive endorsement to have an article in the Financial Times. They know this is big news for business.

Brownie Missed the boat hahaha. . Some big money piled in here 6 months ago @ £2.76 a pop without a hard on ;-))))

That�s what is transformational for this company. Just watch & see what happens when the market wakes up to this.

Results delayed again according to today's RNS as their are some technical discrepancies that have come to light. Add to that they have no financial Director in place after the last one left. It is not looking good at all here.

Buying and smaller pis selling. This sums it up. If people could keep it in their pants this will move rapid.

Now this will go places

IDP raised cash @ £2.76 back in October. The fundementals remain the same but the game has changed with the launch of Prolong. Investors should feel very excited about the progress and innovation and great strides this gem of a company is making. Lots of newsflow due with new product launches as mentioned in the last RNS and also venturing into more international markets. Like I said this is being lined up to be taken out by a major company sooner rather than later. The penny hasn't quite dropped with Prolong the only Erectile Dysfunction product approved by the FDA that's available without prescription and classified as a permanent solution. When it does this will not be what it's worth today but 5-10 times current market cap. Buy Hold and relax

Excellent report inc names of the leading Pharma companies wanting a piece of the pie. https://www.businesswire.com/news/home/20180213006420/en/Global-Erectile-Dysfunction-Market-2018-2023---Market

If you want to make money buy and hold. This has been to �4.20 without Prolong. Not many shares in issue. Great little company making Hugh Hugh strides.